Testim

Known as: Auxilium Pharmaceuticals Inc. Brand of Testosterone 
 
National Institutes of Health

Topic mentions per year

Topic mentions per year

2003-2017
02420032017

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2012
2012
BACKGROUND Testosterone levels naturally decline with age in men, often resulting in testosterone deficiency (hypogonadism… (More)
  • table 1
  • table 2
  • table 3
  • table 4
  • table 5
Is this relevant?
2012
2012
OBJECTIVE Among patients with hypogonadism-associated comorbidities, opioid users have the highest incidence of hypogonadism… (More)
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
2011
2011
INTRODUCTION Up to 30% of erectile dysfunction (ED) patients treated with phosphodiesterase type 5 (PDE5) inhibitors do not show… (More)
Is this relevant?
2011
2011
PURPOSE We measured prostate specific antigen after 12 months of testosterone replacement therapy in hypogonadal men. MATERIALS… (More)
Is this relevant?
2006
2006
BACKGROUND Hypogonadism and anemia are common comorbid conditions in dialysis patients. Testosterone replacement may improve such… (More)
Is this relevant?
Review
2006
Review
2006
Hypogonadism is a medical condition characterised by testosterone deficiency in males, accompanied by numerous clinical symptoms… (More)
Is this relevant?
Review
2005
Review
2005
OBJECTIVE The aim of this work was to review the pharmacokinetic and clinical profile of Testim (Auxilium Pharmaceuticals… (More)
Is this relevant?
2004
2004
A new transdermal preparation, Testim(R) 1% testosterone gel, has recently become available for normalization of serum… (More)
Is this relevant?
2004
2004
Sexual activity, sexual desire, and mood decrease in men with low testosterone levels. The Testim(R) Study of Testosterone… (More)
Is this relevant?
2003
2003
A two-period, randomized, complete crossover study was performed to evaluate the pharmacokinetic profiles of Testim (AA2500), a… (More)
  • table 1
  • figure 1
  • table 2
  • table 3
Is this relevant?